Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Morning Bell 10 September

Bell Direct
September 10, 2024

Morning Bell 9 September

Bell Direct
September 9, 2024

Weekly Wrap 6 September

Bell Direct
September 6, 2024

Morning Bell 5 September

Sam Kanaan
September 5, 2024

Morning Bell 4 September

Bell Direct
September 4, 2024

Morning Bell 3 September

Bell Direct
September 3, 2024

Morning Bell 2 September

Bell Direct
September 2, 2024

Weekly Wrap 30 August

Bell Direct
August 30, 2024

Morning Bell 30 August

Bell Direct
August 30, 2024

Morning Bell 29 August

Bell Direct
August 29, 2024

Morning Bell 28 August

Bell Direct
August 28, 2024